chartexchange

TuHURA Biosciences Reports Third Quarter 2026 Financial Results and Provides a Corporate Update

PR Newswire | Nov 13, 2026 7:45 AM EST

TAMPA, Fla., Nov. 13, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's third quarter...

Read original article